UPDATE: BMO Capital Downgrades Synta Pharma. (SNTA) to Market Perform
Tweet Send to a Friend
(Updated - May 7, 2013 1:05 PM EDT)
BMO Capital downgraded Synta Pharma. (NASDAQ: SNTA) from Outperform to Market ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
BMO Capital downgraded Synta Pharma. (NASDAQ: SNTA) from Outperform to Market ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
